Logan Capital Management Inc Abbott Laboratories Transaction History

Logan Capital Management Inc

$2.34 Billion
Q3 2024

A detailed history of Logan Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Logan Capital Management Inc holds 53,662 shares of ABT stock, worth $6.71 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

53,662

Previous 57,225 6.23%

Holding current value

$6.71 Million

Previous $5.95 Million 2.89%

% of portfolio

0.26%

Previous 0.27%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 06, 2024	SELL	$100.07 - $118.13 $356,549 - $420,897	-3,563 Reduced 6.23%	53,662 $6.12 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $238,024 - $265,695	-2,363 Reduced 3.97%	57,225 $5.95 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $1.12 Million - $1.24 Million	10,215 Added 20.69%	59,588 $6.77 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $306,375 - $375,028	-3,397 Reduced 6.44%	49,373 $5.43 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $179,214 - $215,027	-1,876 Reduced 3.43%	52,770 $5.11 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $83,546 - $93,088	-829 Reduced 1.49%	54,646 $5.96 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $34,869 - $41,043	-360 Reduced 0.64%	55,475 $5.62 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $148,388 - $174,082	1,561 Added 2.88%	55,835 $6.13 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $120,466 - $139,477	-1,245 Reduced 2.24%	54,274 $5.25 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $91,454 - $110,539	896 Added 1.64%	55,519 $6.03 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $2.79 Million - $3.4 Million	-24,455 Reduced 30.93%	54,623 $6.47 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $41,359 - $50,642	358 Added 0.45%	79,078 $11.1 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $551,218 - $609,808	4,725 Added 6.39%	78,720 $9.3 Million
Q2 2021 Aug 17, 2021	BUY	$105.79 - $124.53 $257,598 - $303,230	2,435 Added 3.4%	73,995 $8.58 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $394,980 - $465,346	-3,629 Reduced 4.83%	71,560 $8.58 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $111,825 - $121,857	-1,065 Reduced 1.4%	75,189 $8.23 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $240,188 - $291,691	-2,621 Reduced 3.32%	76,254 $8.3 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $21,133 - $27,048	-276 Reduced 0.35%	78,875 $7.21 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $5,088 - $7,440	-81 Reduced 0.1%	79,151 $6.25 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $91,856 - $102,258	-1,170 Reduced 1.46%	79,232 $6.88 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $134,463 - $145,799	1,643 Added 2.09%	80,402 $6.73 Million
Q2 2019 Jul 24, 2019	BUY	$72.88 - $85.0 $466,504 - $544,085	6,401 Added 8.85%	78,759 $6.62 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $4.79 Million - $5.79 Million	72,358 New	72,358 $5.78 Million

Others Institutions Holding ABT

# of Institutions

3,204

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Account

Logan Capital Management Inc Abbott Laboratories Transaction History